本文へ移動
電子書籍・電子雑誌Glycative stress research
巻号9 (2)
The declin...

The decline of the expression of low density lipoprotein receptor-related protein 1 (LRP1) during normal ageing and in Alzheimer's disease

記事を表すアイコン
表紙は所蔵館によって異なることがあります ヘルプページへのリンク

The decline of the expression of low density lipoprotein receptor-related protein 1 (LRP1) during normal ageing and in Alzheimer's disease

国立国会図書館請求記号
Z63-D541
国立国会図書館書誌ID
032834788
国立国会図書館永続的識別子
info:ndljp/pid/13120769
資料種別
記事
著者
Nikola Barić
出版者
糖化ストレス研究会
出版年
2022-06-30
資料形態
デジタル
掲載誌名
Glycative stress research 9(2)
掲載ページ
-
詳細を見る

国立国会図書館での利用に関する注記

本資料は、掲載誌(URI)等のリンク先にある電子書籍・電子雑誌の提供元Webサイトなどから、本文を自由に閲覧できる場合があります。

資料詳細

要約等:

Considering the importance of the low-density lipoprotein receptor-related protein 1 (LRP1) as the scavenger of harmful waste products from the brain,...

全国の図書館の所蔵

国立国会図書館以外の全国の図書館の所蔵状況を表示します。

所蔵のある図書館から取寄せることが可能かなど、資料の利用方法は、ご自身が利用されるお近くの図書館へご相談ください

その他

書誌情報

この資料の詳細や典拠(同じ主題の資料を指すキーワード、著者名)等を確認できます。

デジタル

資料種別
記事
著者・編者
Nikola Barić
出版年月日等
2022-06-30
出版年(W3CDTF)
2022-06-30
タイトル(掲載誌)
Glycative stress research
巻号年月日等(掲載誌)
9(2)
掲載巻
9(2)
ISSN(掲載誌)
2188-3610
ISSN-L(掲載誌)
2188-3610
本文の言語コード
eng
国立国会図書館永続的識別子
info:ndljp/pid/13120769
コレクション(共通)
コレクション(障害者向け資料:レベル1)
コレクション(個別)
国立国会図書館デジタルコレクション > 電子書籍・電子雑誌 > その他
収集根拠
オンライン資料収集制度
受理日(W3CDTF)
2023-12-08T11:19:22+09:00
保存日(W3CDTF)
2023-05-20
記録形式(IMT)
application/pdf
オンライン閲覧公開範囲
国立国会図書館内限定公開
デジタル化資料送信
図書館・個人送信対象外
遠隔複写可否(NDL)
掲載誌(国立国会図書館永続的識別子)
info:ndljp/pid/13120767
連携機関・データベース
国立国会図書館 : 国立国会図書館デジタルコレクション

デジタル

コレクション(個別)
国立国会図書館デジタルコレクション > 電子書籍・電子雑誌 > その他
オンライン閲覧公開範囲
国立国会図書館内限定公開
デジタル化資料送信
図書館・個人送信対象外
遠隔複写可否(NDL)
所蔵機関
国立国会図書館
請求記号
Z63-D541
関連情報(国立国会図書館永続的識別子)
info:ndljp/pid/13120769
連携機関・データベース
国立国会図書館 : 国立国会図書館雑誌記事索引
書誌ID(NDLBibID)
032834788
整理区分コード
632

デジタル

要約等
Considering the importance of the low-density lipoprotein receptor-related protein 1 (LRP1) as the scavenger of harmful waste products from the brain, especially amyloid beta (Aβ), and as the mediator in a number of signal events, LRP1 is increasingly becoming the object of intensive researches. Alzheimer's disease (AD), as proved, is the result of the disordered Aβ intracerebral homeostasis, characterized by intensive Aβ accumulation in the brain, induced primarily by the Aβ disordered efflux from the brain, and not by its increased production. This elevated Aβ accumulation in the brain structures leads to the increase of the local oxidative stress with intensively harmful effects of the generated free radicals, especially hydroxyl radicals (*OHs). This condition is accompanied by severe oxidative damages of a number of vital brain structures, especially endothelial cell membranes. LRP1, at the level of blood-brain barrier (BBB) endothelial cells, initiated by Aβ binding to its ligand binding domains, especially domains II and IV, induces specific conformational changes in both receptor domains, which causes the onset of pulling forces that, starting from the point of Aβ binding to LRP1, spread along the receptor structure in both directions. Especially important is the spreading of these forces towards the abluminal membrane, their passing across this membrane and entering the receptor tail region and the compound structure of its molecules. The activation of these molecular systems leads to endocytosis, transcytosis, and exocytosis of Aβ bound to the receptor, into the capillary blood of the BBB. The drained Aβ travels further on by the blood stream, exits from the brain, and arrives at the positions of its degradation and elimination, liver, kidneys, spleen, and skin. Investigations have shown that generally, the expression of LRP1 in the BBB endothelial cell system declines during normal ageing, and especially in AD. It is evident that this phenomenon weakens the Aβ drainage from the brain. The actual question is what causes the LRP1 expression drop in these conditions, and if it is possible to slow down this drop. In this respect, this review paper intends to explain the problem of the LRP1 expression decline, and its possible increase, i.e., the retardation of the AD pathophysiological course.
DOI
10.24659/gsr.9.2_42
オンライン閲覧公開範囲
インターネット公開
連携機関・データベース
科学技術振興機構 : J-STAGE

デジタル

要約等
Considering the importance of the low-density lipoprotein receptor-related protein 1 (LRP1) as the scavenger of harmful waste products from the brain, especially amyloid beta (Aβ), and as the mediator in a number of signal events, LRP1 is increasingly becoming the object of intensive researches. Alzheimer's disease (AD), as proved, is the result of the disordered Aβ intracerebral homeostasis, characterized by intensive Aβ accumulation in the brain, induced primarily by the Aβ disordered efflux from the brain, and not by its increased production. This elevated Aβ accumulation in the brain structures leads to the increase of the local oxidative stress with intensively harmful effects of the generated free radicals, especially hydroxyl radicals (*OHs). This condition is accompanied by severe oxidative damages of a number of vital brain structures, especially endothelial cell membranes. LRP1, at the level of blood-brain barrier (BBB) endothelial cells, initiated by Aβ binding to its ligand binding domains, especially domains II and IV, induces specific conformational changes in both receptor domains, which causes the onset of pulling forces that, starting from the point of Aβ binding to LRP1, spread along the receptor structure in both directions. Especially important is the spreading of these forces towards the abluminal membrane, their passing across this membrane and entering the receptor tail region and the compound structure of its molecules. The activation of these molecular systems leads to endocytosis, transcytosis, and exocytosis of Aβ bound to the receptor, into the capillary blood of the BBB. The drained Aβ travels further on by the blood stream, exits from the brain, and arrives at the positions of its degradation and elimination, liver, kidneys, spleen, and skin. Investigations have shown that generally, the expression of LRP1 in the BBB endothelial cell system declines during normal ageing, and especially in AD. It is evident that this phenomenon weakens the Aβ drainage from the brain. The actual question is what causes the LRP1 expression drop in these conditions, and if it is possible to slow down this drop. In this respect, this review paper intends to explain the problem of the LRP1 expression decline, and its possible increase, i.e., the retardation of the AD pathophysiological course.
連携機関・データベース
国立情報学研究所 : CiNii Research
提供元機関・データベース
Japan Link Center
雑誌記事索引データベース
雑誌記事索引データベース